{"id":129436,"date":"2023-01-30T08:36:04","date_gmt":"2023-01-30T08:36:04","guid":{"rendered":"https:\/\/ccs.ca\/?post_type=event&#038;p=129436"},"modified":"2023-02-02T08:15:29","modified_gmt":"2023-02-02T08:15:29","slug":"ccs-2022-cardiorenal-guidelines-in-action","status":"publish","type":"event","link":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/","title":{"rendered":"CCS 2022 Cardiorenal Guidelines in Action"},"content":{"rendered":"\n<p>Putting the Canadian Cardiovascular Society 2022 Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults into Action.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Learning Objectives<\/h5>\n\n\n\n<p>Participants will:<\/p>\n\n\n\n<ul><li>Be updated on the rapidly evolving evidence base supporting use of SGLT2i and GLP-1 RA for cardiorenal risk reduction (Leader, Collaborator, Professional, Expert, Communicator, Scholar)<\/li><li>Be able to identify opportunities for use of SGLT2i and GLP-1 RA in patients with heart failure or chronic kidney disease with or without type 2 diabetes (Leader, Collaborator, Professional, Expert, Communicator, Scholar)<\/li><li>Be confident in implementing these new classes through understanding safe strategies for implementation and avoidance of side effects (Leader, Collaborator, Professional, Expert, Communicator, Scholar)<\/li><\/ul>\n\n\n\n<p>Panelists: Dr. John Mancini (moderator), Dr. Eileen O&#8217;Meara, Dr. Alice Cheng, Dr. David Cherney and Dr. David Bewick.<\/p>\n","protected":false},"featured_media":0,"template":"","event_type":[147],"topic":[390],"royal_college_moc":[],"wf_event_folders":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CCS 2022 Cardiorenal Guidelines in Action - Canadian Cardiovascular Society<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CCS 2022 Cardiorenal Guidelines in Action - Canadian Cardiovascular Society\" \/>\n<meta property=\"og:description\" content=\"Putting the Canadian Cardiovascular Society 2022 Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults into Action. Learning Objectives Participants will: Be updated on the rapidly evolving evidence base supporting use of SGLT2i and GLP-1 RA for cardiorenal risk reduction (Leader, Collaborator, Professional, Expert, Communicator, Scholar) Be able [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Cardiovascular Society\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-02T08:15:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@SCC_CCS\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/\",\"url\":\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/\",\"name\":\"CCS 2022 Cardiorenal Guidelines in Action - Canadian Cardiovascular Society\",\"isPartOf\":{\"@id\":\"https:\/\/ccs.ca\/#website\"},\"datePublished\":\"2023-01-30T08:36:04+00:00\",\"dateModified\":\"2023-02-02T08:15:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Events\",\"item\":\"https:\/\/ccs.ca\/latest-events\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CCS 2022 Cardiorenal Guidelines in Action\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ccs.ca\/#website\",\"url\":\"https:\/\/ccs.ca\/\",\"name\":\"Canadian Cardiovascular Society\",\"description\":\"Strong heart teams in a heart-healthy Canada.\",\"publisher\":{\"@id\":\"https:\/\/ccs.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ccs.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ccs.ca\/#organization\",\"name\":\"Canadian Cardiovascular Society\",\"url\":\"https:\/\/ccs.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"contentUrl\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"width\":699,\"height\":250,\"caption\":\"Canadian Cardiovascular Society\"},\"image\":{\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\",\"https:\/\/x.com\/SCC_CCS\",\"https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CCS 2022 Cardiorenal Guidelines in Action - Canadian Cardiovascular Society","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/","og_locale":"en_US","og_type":"article","og_title":"CCS 2022 Cardiorenal Guidelines in Action - Canadian Cardiovascular Society","og_description":"Putting the Canadian Cardiovascular Society 2022 Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults into Action. Learning Objectives Participants will: Be updated on the rapidly evolving evidence base supporting use of SGLT2i and GLP-1 RA for cardiorenal risk reduction (Leader, Collaborator, Professional, Expert, Communicator, Scholar) Be able [&hellip;]","og_url":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/","og_site_name":"Canadian Cardiovascular Society","article_publisher":"https:\/\/www.facebook.com\/SCC.CCS.ca\/","article_modified_time":"2023-02-02T08:15:29+00:00","twitter_card":"summary_large_image","twitter_site":"@SCC_CCS","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/","url":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/","name":"CCS 2022 Cardiorenal Guidelines in Action - Canadian Cardiovascular Society","isPartOf":{"@id":"https:\/\/ccs.ca\/#website"},"datePublished":"2023-01-30T08:36:04+00:00","dateModified":"2023-02-02T08:15:29+00:00","breadcrumb":{"@id":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ccs.ca\/event\/ccs-2022-cardiorenal-guidelines-in-action\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Events","item":"https:\/\/ccs.ca\/latest-events\/"},{"@type":"ListItem","position":2,"name":"CCS 2022 Cardiorenal Guidelines in Action"}]},{"@type":"WebSite","@id":"https:\/\/ccs.ca\/#website","url":"https:\/\/ccs.ca\/","name":"Canadian Cardiovascular Society","description":"Strong heart teams in a heart-healthy Canada.","publisher":{"@id":"https:\/\/ccs.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ccs.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ccs.ca\/#organization","name":"Canadian Cardiovascular Society","url":"https:\/\/ccs.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/","url":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","contentUrl":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","width":699,"height":250,"caption":"Canadian Cardiovascular Society"},"image":{"@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SCC.CCS.ca\/","https:\/\/x.com\/SCC_CCS","https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society"]}]}},"_links":{"self":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/event\/129436"}],"collection":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/event"}],"about":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/types\/event"}],"wp:attachment":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/media?parent=129436"}],"wp:term":[{"taxonomy":"event_type","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/event_type?post=129436"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/topic?post=129436"},{"taxonomy":"royal_college_moc","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/royal_college_moc?post=129436"},{"taxonomy":"wf_event_folders","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/wf_event_folders?post=129436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}